HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company’s business strategy and commercial and development-stage programs will be given at Cantor Fitzgerald’s 2nd Annual Healthcare Conference being held at the Le Parker Meridien in New York City. The Company presentation is on Wednesday, July 13th, 2016, at 2:30 PM ET.
